You are here

IPOs

These 4 Biotechs Have Selling Pressure on the Horizon

Motley Fool

Sun, 03/8/20 - 11:29 pm

Frequency Therpeutics

Aprea Therapeutics

Vir Biotechnology

ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers

Xconomy

Mon, 03/2/20 - 11:14 pm

ORIC Pharmaceuticals

Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO

Endpoints

Fri, 02/28/20 - 10:37 am

Top 10 biotech IPOs in 2019

Fierce Biotech

Mon, 02/24/20 - 10:52 am

Blood disorder startup files for $86M IPO

Bizjournals

Wed, 02/19/20 - 09:52 am

sickle cell disease

beta thalassemia

Pfizer-backed biopharma company Imara files for IPO

Marketwatch

Sat, 02/15/20 - 02:23 pm

hemoglobinopathies

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

Xconomy

Thu, 02/13/20 - 12:06 am

Revolution Medicines

Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered

Xconomy

Thu, 02/6/20 - 11:49 pm

Beam Therapeutics

Drug research firm PPD prices IPO at top end of target

Reuters

Thu, 02/6/20 - 10:58 am

The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus

Yahoo/Benzinga

Mon, 02/3/20 - 10:37 am

Jounce Therapeutics

Catalyst Biosciences

Kodiak Sciences

Adverum Biotechnologies

Beam Therapeutics

Pandemic fears force Chinese biotech to postpone Hong Kong IPO meetings — Bloomberg

Endpoints

Mon, 02/3/20 - 10:30 am

Wuhan Coronavirus

InnoCare Pharma

Oncology biotech Revolution Medicines sets terms for $150 million IPO

NASDAQ

Mon, 02/3/20 - 10:27 am

Revolution Medicines

Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs

Xconomy

Mon, 02/3/20 - 12:00 am

Arcutis Biotherpeutics

Mammoth Biosciences Raises $45 Million For Crispr Diagnostics—And Its Tech Is Already Being Used Against Coronavirus

Forbes

Thu, 01/30/20 - 09:44 pm

Mammoth Biosciences

Rani Therapeutics eyes potential IPO as robotic pill technology takes shape

Endpoints

Thu, 01/30/20 - 10:40 am

Rani Therapeutics

Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins

Xconomy

Wed, 01/29/20 - 11:59 pm

neurodegenerative disease

Deerfield vaults to the top of cell and gene therapy CDMO game with $1.1B facility at Philadelphia's newest biopharma hub

Endpoints

Sat, 01/25/20 - 11:27 pm

Deerfield Management

Poor fourth quarter mars strong year for medtech floats

EP Vantage

Tue, 01/21/20 - 11:51 am

Smile Direct Club

Silk Road Medical

Adaptive Biotechnologies

Shockwave Medical

Castle Biosciences

Will This Be the Next Big Healthcare IPO?

Motley Fool

Sat, 01/18/20 - 07:36 pm

After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO

Fierce Biotech

Fri, 01/17/20 - 12:08 pm

I-Mab Biopharma

autoimmune disease

Pages